Cargando…

Disease-directed engineering for physiology-driven treatment interventions in neurological disorders

Neurological disease is killing us. While there have long been attempts to develop therapies for both acute and chronic neurological diseases, no current treatments are curative. Additionally, therapeutic development for neurological disease takes 15 years and often costs several billion dollars. Mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Wood, Thomas, Nance, Elizabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AIP Publishing LLC 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811362/
https://www.ncbi.nlm.nih.gov/pubmed/31673672
http://dx.doi.org/10.1063/1.5117299
_version_ 1783462462237966336
author Wood, Thomas
Nance, Elizabeth
author_facet Wood, Thomas
Nance, Elizabeth
author_sort Wood, Thomas
collection PubMed
description Neurological disease is killing us. While there have long been attempts to develop therapies for both acute and chronic neurological diseases, no current treatments are curative. Additionally, therapeutic development for neurological disease takes 15 years and often costs several billion dollars. More than 96% of these therapies will fail in late stage clinical trials. Engineering novel treatment interventions for neurological disease can improve outcomes and quality of life for millions; however, therapeutics should be designed with the underlying physiology and pathology in mind. In this perspective, we aim to unpack the importance of, and need to understand, the physiology of neurological disease. We first dive into the normal physiological considerations that should guide experimental design, and then assess the pathophysiological factors of acute and chronic neurological disease that should direct treatment design. We provide an analysis of a nanobased therapeutic intervention that proved successful in translation due to incorporation of physiology at all stages of the research process. We also provide an opinion on the importance of keeping a high-level view to designing and administering treatment interventions. Finally, we close with an implementation strategy for applying a disease-directed engineering approach. Our assessment encourages embracing the complexity of neurological disease, as well as increasing efforts to provide system-level thinking in our development of therapeutics for neurological disease.
format Online
Article
Text
id pubmed-6811362
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher AIP Publishing LLC
record_format MEDLINE/PubMed
spelling pubmed-68113622019-10-31 Disease-directed engineering for physiology-driven treatment interventions in neurological disorders Wood, Thomas Nance, Elizabeth APL Bioeng Perspectives Neurological disease is killing us. While there have long been attempts to develop therapies for both acute and chronic neurological diseases, no current treatments are curative. Additionally, therapeutic development for neurological disease takes 15 years and often costs several billion dollars. More than 96% of these therapies will fail in late stage clinical trials. Engineering novel treatment interventions for neurological disease can improve outcomes and quality of life for millions; however, therapeutics should be designed with the underlying physiology and pathology in mind. In this perspective, we aim to unpack the importance of, and need to understand, the physiology of neurological disease. We first dive into the normal physiological considerations that should guide experimental design, and then assess the pathophysiological factors of acute and chronic neurological disease that should direct treatment design. We provide an analysis of a nanobased therapeutic intervention that proved successful in translation due to incorporation of physiology at all stages of the research process. We also provide an opinion on the importance of keeping a high-level view to designing and administering treatment interventions. Finally, we close with an implementation strategy for applying a disease-directed engineering approach. Our assessment encourages embracing the complexity of neurological disease, as well as increasing efforts to provide system-level thinking in our development of therapeutics for neurological disease. AIP Publishing LLC 2019-10-23 /pmc/articles/PMC6811362/ /pubmed/31673672 http://dx.doi.org/10.1063/1.5117299 Text en © Author(s). 2473-2877/2019/3(4)/040901/20 All article content, except where otherwise noted, is licensed under a Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Perspectives
Wood, Thomas
Nance, Elizabeth
Disease-directed engineering for physiology-driven treatment interventions in neurological disorders
title Disease-directed engineering for physiology-driven treatment interventions in neurological disorders
title_full Disease-directed engineering for physiology-driven treatment interventions in neurological disorders
title_fullStr Disease-directed engineering for physiology-driven treatment interventions in neurological disorders
title_full_unstemmed Disease-directed engineering for physiology-driven treatment interventions in neurological disorders
title_short Disease-directed engineering for physiology-driven treatment interventions in neurological disorders
title_sort disease-directed engineering for physiology-driven treatment interventions in neurological disorders
topic Perspectives
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811362/
https://www.ncbi.nlm.nih.gov/pubmed/31673672
http://dx.doi.org/10.1063/1.5117299
work_keys_str_mv AT woodthomas diseasedirectedengineeringforphysiologydriventreatmentinterventionsinneurologicaldisorders
AT nanceelizabeth diseasedirectedengineeringforphysiologydriventreatmentinterventionsinneurologicaldisorders